Lenacapavir (LEN) is an antiviral medication used to treat and prevent HIV/AIDS and was first approved for individuals with ...
Gilead study finds HIV can evolve to resist lenacapavir, but doing so hampers the virus' replication
Now, Gilead has conducted an analysis of a phenomenon that can undermine all infectious disease therapies, including lenacapavir—HIV’s ability to evolve resistance to the breakthrough antiviral.
Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...
Morning Overview on MSN
The 'mutant' humans who shrug off every known virus
Across the world, only a few dozen people appear to carry a genetic glitch that lets them brush off viruses that flatten ...
Morning Overview on MSN
Ancient DNA exposes virus that hacked its way into human genes
Ancient DNA is turning human evolution into a crime scene reconstruction, and one of the prime suspects is a herpesvirus that ...
Learn how a newly discovered virus disrupts its host’s nucleus in ways that echo how complex cells may have formed billions ...
The mosquito-borne Zika virus hijacks a host protein called ANKLE2 to support its own reproduction. ANKLE2 is involved in brain development in the fetus and because Zika can cross the placenta and ...
Researchers have discovered that virus-like nanoparticles can promote the multicellular organization and reproduction of host bacteria. These particles, which are evolutionarily related to phages ...
The mosquito-borne Zika virus is known for causing microcephaly, a birth defect in which abnormal brain development results in a smaller-than-expected head. A new study published Jan. 13 in mBio shows ...
Ushikuvirus is a newly identified giant virus that infects amoebas, adding to a growing group of oversized viruses that scientists believe may have played an important role in the emergence of complex ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results